Trupanion (NASDAQ:TRUP) Shares Gap Up – What’s Next?

Trupanion, Inc. (NASDAQ:TRUP) shares gapped up prior to trading on Thursday . The stock had previously closed at $46.52, but opened at $49.18. Trupanion shares last traded at $46.90, with a volume of 74,849 shares.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on TRUP shares. Piper Sandler upgraded shares of Trupanion from a “neutral” rating to an “overweight” rating and set a $57.00 target price for the company in a research note on Thursday. Stifel Nicolaus upped their price target on shares of Trupanion from $42.00 to $44.00 and gave the stock a “hold” rating in a research report on Monday, January 6th. Finally, Northland Securities raised their target price on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $45.33.

Trupanion Price Performance

The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. The firm’s 50 day moving average price is $50.60 and its two-hundred day moving average price is $45.97.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The business had revenue of $327.50 million during the quarter, compared to analysts’ expectations of $321.79 million. During the same period in the prior year, the business posted ($0.10) EPS. The company’s revenue was up 14.6% compared to the same quarter last year. As a group, equities analysts forecast that Trupanion, Inc. will post -0.2 earnings per share for the current fiscal year.

Insider Buying and Selling at Trupanion

In related news, Director Murray B. Low sold 2,000 shares of Trupanion stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $52.67, for a total value of $105,340.00. Following the completion of the transaction, the director now owns 131,513 shares in the company, valued at approximately $6,926,789.71. The trade was a 1.50 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Fawwad Qureshi sold 9,867 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $53.08, for a total transaction of $523,740.36. The disclosure for this sale can be found here. Insiders have sold a total of 28,597 shares of company stock valued at $1,522,082 over the last quarter. 5.50% of the stock is owned by company insiders.

Institutional Investors Weigh In On Trupanion

A number of hedge funds have recently bought and sold shares of the stock. Quest Partners LLC purchased a new stake in shares of Trupanion in the 3rd quarter valued at about $37,000. Wilmington Savings Fund Society FSB acquired a new stake in shares of Trupanion in the third quarter valued at approximately $54,000. GAMMA Investing LLC increased its position in Trupanion by 70.4% in the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider’s stock valued at $61,000 after acquiring an additional 596 shares during the period. KBC Group NV purchased a new position in Trupanion during the 4th quarter worth $75,000. Finally, R Squared Ltd acquired a new stake in shares of Trupanion in the 4th quarter valued at approximately $79,000.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.